+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Meperidine Market 2020-2026

  • PDF Icon


  • June 2020
  • Region: Global
  • Orion Market Research Private Limited
  • ID: 5129651
Global Meperidine Market Size, Share & Trends Analysis Report, By Application (Pain Relief, and Anesthesia), By Dosage type (Oral, and Injections) and Forecast, 2020-2026

The meperidine market is expected to show steady growth during the forecast period. It is offered under the brand name Demerol by Pfizer Inc. It is an opioid class analgesic drug, similar to morphine. Due to this, the drug needs a prescription to purchase in most of the countries. It is widely used to relieve a person from moderate to severe pain. Moreover, it is also used during or before surgery or other procedures. However, the drug cannot be used to treat long-term or on-going pain and is used only when the pain is sudden.

Rising cosmetic surgical procedures globally is a major factor for the growth of the market during the forecast period. Moreover, increasing cardiovascular, neurological, surgeries are also motivating the market growth. However, side effects related to the drug such as vomiting, constipation, sweating, lightheadedness, its alternatives available and decrease in the prescriptions to the patients are some of the restraining factors for the market growth.

The global meperidine market is divided on the basis of application and dosage type. Based on application, the market is further bifurcated into pain relief and anesthesia. By dosage type, the market is bifurcated into oral and injections. The market is also studied on the basis of geography. Based on geography, the global meperidine market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). During the forecast period, North America is expected to have a major market share. Europe is also expected to hold a considerable market share and Germany, UK, and France will hold a noticeable market share in the region. In addition, Asia-Pacific region is expected to show significant growth during the forecast period. Rising medical tourism, increasing medical surgeries, are some of the major factors motivating the market growth in Asia-Pacific.

Key players acting in the market include Boehringer Ingelheim International GmbH, Neon Laboratories Ltd., Pfizer Inc., Mallinckrodt plc, and Hikma Pharmaceuticals PLC. The market players are adopting growth strategies including mergers & acquisitions, product launches, and partnerships & collaborations to gain a competitive edge in the market.

Research Methodology

The market study of the global meperidine market is incorporated by extensive primary and secondary research. Secondary research has been conducted to breakdown the market in various segments; derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.

In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts to amplify the added validity of the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market
  • Authentic public databases
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:
  • Global Meperidine Market Research and Analysis, By Application
  • Global Meperidine Market Research and Analysis, By Dosage Type

The Report covers:
  • Comprehensive research methodology of the Global Meperidine Market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global Meperdine Market.
  • Insights about market determinants which are stimulating the Global Meperidine Market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdowns
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
4. Market Determinants
4.1 Motivators
4.2 Restraints
4.3 Opportunities
5. Market Segmentation
5.1. Global Meperidine Market by Application
5.1.1. Pain Relief
5.1.2. Anaesthesia
5.2. Global Meperidine Market by Dosage type
5.2.1. Oral
5.2.2. Injections
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. France
6.2.4. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Boehringer Ingelheim International GmbH
7.2. Neon Laboratories Ltd.
7.3. Pfizer Inc.
7.4. Mallinckrodt plc
7.5. Hikma Pharmaceuticals PLC

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Boehringer Ingelheim International GmbH
  • Neon Laboratories Ltd.
  • Pfizer Inc.
  • Mallinckrodt plc
  • Hikma Pharmaceuticals PLC